Automated keratometry gives better results than Scheimpflug keratometry

Article

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry.

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry, according to a study published in the Journal of Cataract and Refractive Surgery.

Dr Sheridan Lam et al., DuPage Ophthalmology, Lombard, Illinois, USA, conducted a comparative case series on 110 eyes of 76 virgin cornea patients (Group 1) and 137 eyes of 94 control group participants also with virgin corneas (Group 2). Each group underwent phacoemulsification with implantation of a posterior chamber intraocular lens (IOL) and ultrasound biometry.

Group 1 underwent Scheimpflug keratometry based on pupil size and group 2 had conventional automated keratometry. The Holladay 2 formula was used to evaluate IOL power. Refractive outcomes and keratometry (K) readings were assessed by statistical analysis.

In group 1 the mean K reading and mean absolute refractive error was 43.45 D and 0.480 D, respectively. In group 2 it was 43.51 D and 0.252 D, respectively- meaning the absolute refractive error between the two groups was statistically significant.

Of the 110 eyes studied in group 1, 77 were within ±0.50 D of the intended postoperative refraction, 28 were between ±0.50 D and ±1.00 D, 4 were between ±1.00 D and ±1.50 D, and 1 was between ±1.50 D and ±2.00 D. Group 2 saw 131 eyes within ±0.50 D, 3 were between ±0.50 D and ±1.00 D, and 3 were between ±1.00 D and ±1.50 D. The findings were described as statistically significant between the 2 groups.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.